A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
JJJesse J. SwenCHCathelijne H. van der WoudenLELisanne E. N. MansonHAH. Abdullah-KoolmeesKBKathrin Blagec
Leiden University · University Medical Center Utrecht · +29 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
498
total citations
- FWCI
- 122.58
- Percentile
- 100%
- References
- 26
Citations per year
Authors
257Topics & keywords
Topics
Keywords
- Pharmacogenetics
- Medicine
- Crossover study
- Drug
- Adverse effect
- Crossover
- Drug reaction
- Cluster (spacecraft)
No related works found for this paper.
Funding
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- AAstraZeneca
- GSGilead Sciences
- UCUnion Chimique Belge
- RBRobert Bosch Stiftung
- DFDeutsche ForschungsgemeinschaftAwards: EXC 2180-390900677, EXC 2180, 390900677
- SServier
- H2Horizon 2020 Framework Programme
- HEHORIZON EUROPE Framework ProgrammeAward: 668353
- MRMedical Research CouncilAwards: MR/S000933/1, MR/L006758/1
- EAEngineering and Physical Sciences Research Council